FDA inspection
Smithkline Beecham (Cork) Inc.: FDA inspection ending Dec 2, 2003
FDA inspection 314114 · Official Action Indicated (OAI) · Cidra, PR
Key facts
| Inspection ID | 314114 |
|---|---|
| Firm | Smithkline Beecham (Cork) Inc. |
| FEI number | 1000132065 |
| Address | Carr # 172, Km 9.1, Barrio Bayamon, Sector Certenejas |
| City | Cidra |
| State | PR |
| ZIP | 00739 |
| Fiscal year | 2004 |
| Inspection end date | Dec 2, 2003 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data